The U.S. Defense Health Agency has awarded a $1,602,424.00 Project Grant to The Mclean Hospital Corporation Research Management Division, doing business as Mclean Hospital, for the project "APOE AND LIPID MECHANISMS RELEVANT TO COGNITIVE DYSFUNCTION IN PARKINSON'S DISEASE". The award, which runs from Sep 1, 2023 to Aug 31, 2027, is funded through the Military Medical Research and Development program (CFDA 12.420). The goal of this research is to investigate medical solutions for the battlefield by transforming health care for Service Members and the American public through innovative and impactful neuroscience and mental health research. Mclean Hospital, a nonprofit psychiatric teaching hospital affiliated with Harvard Medical School, has a history of prime federal contract awards in diverse areas like neuroscience, mental health disorders, substance abuse, and technology in psychiatry.
Generated 5/14/24, 10:16 AM